The results from several studies indicate that erythropoietic EPO is therapeutic for a broad range of neurodegenerative diseases such as axonal degeneration, peripheral nerve injury, experimental brain injury, and Alzheimer’s disease [51,52,53,54,55]. The gene discussed is EPO; the disease is early-onset autosomal dominant Alzheimer disease.